Trials / Completed
CompletedNCT01667796
Pharmacokinetics of Vitamin D in Multiple Sclerosis and in Health
Pharmacodynamic and Immunologic Effects of Vitamin D Supplementation in Patients With Multiple Sclerosis and Healthy Controls
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This is a pilot study of oral vitamin D supplementation to determine if patients with Multiple Sclerosis (MS) and healthy individuals attain a similar increase in serum 25-hydroxyvitamin D levels. The investigators will also assess whether the immunologic or relevant gene expression response to oral vitamin D supplementation differs in patients with MS and healthy controls.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Vitamin D3 |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2014-03-01
- Completion
- 2014-03-01
- First posted
- 2012-08-17
- Last updated
- 2019-03-05
- Results posted
- 2016-02-01
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01667796. Inclusion in this directory is not an endorsement.